A patent analytics study of the Australian pharmaceutical industry
March 24, 2017Medical Communications Australia, patent, pharmaceutical
This report provides an analysis of the Australian pharmaceutical and biopharmaceutical industry through the lens of patents. By using the …
Research found to reverse signs of ageing in mice
March 24, 2017Medical Communications, Research and Development Aging
A new study has emerged that reveals another clue into the process of ageing and how, on a cellular level, …
Sanofi looks to close $1 billion deal Flexion
March 24, 2017Medical Communications, Sales and Marketing Sanofi, flexion therapeutics, osteo
According to reports emerging, Sanofi may be on the verge of closing a deal with Burlington-based biotech, Flexion Therapeutics. The …
DrugDev signs up George Masoura as Vice President of Business Development
March 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment
DrugDev has announced the appointment of George Masoura who has joined the company as Vice President, Business Development, Europe to …
Advent reportedly backs out of bid for Pfizer’s Brazil plant
March 23, 2017Sales and Marketing Brazil, Pfizer, generics
It has been reported that Advent International Corp has pulled out of bidding for Pfizer’s stake in Brazilian generics manufacturer, …
Injectable drug market to grow to $625 billion worldwide by 2021
March 23, 2017Sales and Marketing injectable drugs, injectables
New data released by intelligence firm MarketsandMarkets indicates that the global injectable drug market is set to reach $625 billion …
Drug prices set to increase on ‘essential medicines’ list in India
March 23, 2017Sales and Marketing Indian
The annual review of drug prices will see the price of drugs, on the National List of Essential Medicines, increase …
GSK and Regeneron partner with Biobank to analyse 500,000 genetic profiles
March 23, 2017Research and Development Biobank, GSK, Regeneron
GlaxoSmithKline and Regeneron Pharmaceuticals are to band together in a joint effort with UK Biobank – “the world’s most detailed …
Shire’s drug picked up from Baxalta given fast track designation
March 23, 2017Research and Development, Sales and Marketing Shire, rare diseases
Shire has announced that its drug, SHP655, has received a fast track designation based on pre-clinical trials and positive results …
FDA approves first Parkinson’s treatment in a decade
March 22, 2017Research and Development, Sales and Marketing FDA, Parkinson's, Xadago
The FDA has approved Xadago (safinamide) as a supplementary treatment for Parkinson’s in patients currently taking levodopa/carbidopa and who are …
Alternative treatment cures rare blood disease for first time
March 22, 2017Research and Development congenital dyserythropoietic anaemia
A Chicago man has become the first person ever documented to be cured of congenital dyserythropoietic anaemia (CDA), a rare …
GSK begins £92 million expansion of UK site
March 22, 2017Manufacturing and Production, Research and Development GSK, UK
GSK has officially broken ground on the expansion of its site in County Durham. The expanded site will be an …
Novartis heart failure drug sinks at Phase 3 trials
March 22, 2017Research and Development Acute heart failure, Novartis, serelaxin
Novartis’ serelaxin was once thought to be the major hope for its cardiovascular pipeline – analysts projected it to become …
Novartis’ psoriasis drug allows some patients to go into remission
March 21, 2017Research and Development Cosentyx, Novartis, psoriasis
Novartis released data on patient’s reaction to Cosentyx for the treatment of psoriasis, finding that as many as 21% of …
Asia-Pacific NSCLC market to more than double to $6.2bn by 2023
March 21, 2017Manufacturing and Production, Research and Development, Sales and Marketing BMS, Eli Lilly, MSD, NSCLC, Yervoy, keytruda, opdivo
New research from intelligence provider GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific …
Lilly’s breast cancer drug meets primary endpoint
March 21, 2017Manufacturing and Production, Research and Development CDK 4/6 inhibitors, Eli Lilly, abemaciclib
Eli Lilly has announced that its trial of abemaciclib, in combination with fulvestrant, had met its primary endpoint of progression-free …
India aims to become “a global innovation hub” for biotechs by 2020
March 21, 2017Manufacturing and Production, Research and Development India, biotech
The Indian Government has announced its intention to transform the nation into a hub for global biotech activity via its …
Biogaran acquires production foothold in Nigeria with Swipha acquisition
March 21, 2017Manufacturing and Production, Sales and Marketing Biogaran, Swipharma
Biogaran, the French generic manufacturer that is a subsidiary of Servier, has acquired a foothold in Nigeria with a 95% …
Array BioPharma in disarray over withdrawal of NDA
March 20, 2017Manufacturing and Production, Sales and Marketing Array Biopharma
Array BioPharma has announced that it has pulled its new drug application (NDA) for its drug, binimetinib, for the treatment …
Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures
March 20, 2017Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche
Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
